Effect of valsartan combined with sulodexide on diabetic nephropathy
Yulin Wang, Zijun Yang, Liuwei Wang, Jun-tong Chen, Lin Tang
Abstract
Yulin Wang, Zijun Yang, Liuwei Wang, Jun-tong Chen, Lin Tang
Abstract
Objective To observe the effect of the combined therapy of valsartan and sulodexide on diabetic nephropathy(DN).Methods Thirty-six patients with DN-Ⅲ stage and thirty-six patients with DN-Ⅳ stage were randomized divided into valsartan group,sulodexide group,valsartan and sulodexide group,each group had 12 patients.The follow-up was 12 weeks.Then the UAER,24 h urinary protein,serum creatinine,blood lipid,plasma albumin were measured.Results After treatment of 12 weeks,the level of UAER of DN-Ⅲ stage and 24 h urinary protein of DN-Ⅳ stage decreased significantly in all the three groups,and no significant difference was observed between valsartan group and sulodexide group(P > 0.05)in the two stages,but significant difference was noted compared with combined therapy group(P < 0.05).Conclusions Valsartan combined with sulodexide can effectively decrease the level of urine protein in patients with DN and the effect is better than single application. Key words: Diabetic nephropathy ; Sulodexide ; Valsartan
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the effect of the combined therapy of valsartan and sulodexide on diabetic nephropathy(DN).Methods Thirty-six patients with DN-Ⅲ stage and thirty-six patients with DN-Ⅳ stage were randomized divided into valsartan group,sulodexide group,valsartan and sulodexide group,each group had 12 patients.The follow-up was 12 weeks.Then the UAER,24 h urinary protein,serum creatinine,blood lipid,plasma albumin were measured.Results After treatment of 12 weeks,the level of UAER of DN-Ⅲ stage and 24 h urinary protein of DN-Ⅳ stage decreased significantly in all the three groups,and no significant difference was observed between valsartan group and sulodexide group(P > 0.05)in the two stages,but significant difference was noted compared with combined therapy group(P < 0.05).Conclusions Valsartan combined with sulodexide can effectively decrease the level of urine protein in patients with DN and the effect is better than single application. Key words: Diabetic nephropathy ; Sulodexide ; Valsartan
Key concepts: Valsartan, Medicine, Diabetic nephropathy, Creatinine, Urology, Internal medicine, Endocrinology, Urinary system